Skip to main content
SpringerLink
Log in

Targeted protection of hepatocytes from galactosamine toxicity in vivo

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

We present an in vivo model for specific protection of normal hepatocytes from damage by the highly specific hepatotoxin galactosamine. The idea is based on the fact that normal, unlike malignant, hepatocytes possess unique cell-surface receptors that can bind and internalize galactose terminal (asialo)glycoproteins by receptor-mediated endocytosis. A targetable carrier-antagonist conjugate was formed by coupling asialofetuin to the galactosamine antagonist uridine monophosphate. Intravenous injection of the antagonist conjugate resulted in specific uptake by the liver. Rats treated with carrier-antagonist conjugate together with a toxic dose of galactosamine developed significantly less hepatotoxicity than did controls. We conclude that a galactosamine antagonist can be targeted to liver, resulting in specific protection of hepatocytes from galactosamine toxicity in vivo. Because hepatoma cells lack asialoglycoprotein receptor activity, this “targeted rescue” may be of value in the differential protection of normal cells in the treatment of hepatocellular carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AsF:

asialofetuin

PL:

polyl-lysine

UMP:

5′-uridine monophosphate

ALT:

alanine aminotransferase

AsOR:

asialoorosomucoid

References

  1. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41: 99

    PubMed  CAS  Google Scholar 

  2. Bertoli D, Segal S (1966) Developmental aspects and some characteristics of mammalian galactose 1-phosphate uridyltransferase. J Biol Chem 241: 4023

    PubMed  CAS  Google Scholar 

  3. Chojkier M, Fierer J (1985)d-Galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 88: 115

    PubMed  CAS  Google Scholar 

  4. Cuatrecasas P, Segal S (1965) Mammalian galactokinase: developmental and adaptive characteristics in the rat liver. J Biol Chem 240: 2382

    PubMed  CAS  Google Scholar 

  5. Decker K, Keppler D (1974) Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 71: 77

    Article  PubMed  CAS  Google Scholar 

  6. Dunn WA, Hubbard AL, Aronson NN Jr (1980) Low temperature selectively inhibits fusion between pinocytic vesicles and lysosomes during heterophagy of125I-asialofetuin by the perfused rat liver. J Biol Chem 255: 5971

    PubMed  CAS  Google Scholar 

  7. Farber JL (1982) Biology of disease: membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis. Lab Invest 47: 114

    PubMed  CAS  Google Scholar 

  8. Grun M, Liehr H, Grun W, Rasenack U, Brunswig D (1974) Influence of liver-RES on toxic liver damage due to galactosamine. Acta Hepato-Gastroenterol 21: 5

    CAS  Google Scholar 

  9. Halloran MJ, Parker CW (1966) The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents. J Immunol 96: 373

    PubMed  CAS  Google Scholar 

  10. Jackson RC, Williams JC, Weber G (1976) Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine withd-galactosamine. Cancer Treat Rep 60: 835

    PubMed  CAS  Google Scholar 

  11. Keppler D (1975) Consequences of uridine triphosphate deficiency in liver and hepatoma cells.In: Pathogenesis and mechanisms of liver cell necrosis. University Park, Baltimore, p 87

    Google Scholar 

  12. Keppler D (1978) Approaches to the chemotherapy of hepatomas.In: Primary liver tumors. MTP, Lancaster, p 485

    Google Scholar 

  13. Keppler D, Decker K (1969) Studies on the mechanism of galactosamine hepatitis: accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem 10: 219

    Article  PubMed  CAS  Google Scholar 

  14. Keppler DOR (1977) Uridine triphosphate deficiency, growth inhibition, and death in ascites hepatoma cells induced by a combination of pyrimidine biosynthesis inhibition with uridylate trapping. Cancer Res 37: 911

    PubMed  CAS  Google Scholar 

  15. Keppler DOR, Smith DF (1974) Nucleotide contents of ascites hepatoma cells and their changes induced byd-galactosamine. Cancer Res 34: 705

    PubMed  CAS  Google Scholar 

  16. Keppler DOR, Rudigier JFM, Bischoff E, Decker KFA (1970) The trapping of uridine phosphates byd-galactosamine,d-glucosamine, and 2-deoxy-d-galactose: a study on the mechanism of galactosamine hepatitis. Eur J Biochem 17: 246

    Article  PubMed  CAS  Google Scholar 

  17. Keppler DOR, Pausch J, Decker K (1974) Selective uridine triphosphate deficiency induced byd-galactosamine in liver and reversed by pyrimidine nucleotide precursors. J Biol Chem 249: 211

    PubMed  CAS  Google Scholar 

  18. Liehr H, Grun M, Seelig H-P, Seelig R, Reutter W, Heine W-D (1978) On the pathogenesis of galactosamine hepatitis: indications of extrahepatocellular mechanisms responsible for liver cell death. Virchows Arch [Cell Pathol] 26: 331

    CAS  Google Scholar 

  19. MacDonald JR, Gandolfi AJ, Sipes IG (1985) Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis. Toxicol Appl Pharmacol 81: 17

    Article  PubMed  CAS  Google Scholar 

  20. MacDonald JR, Thayer KJ, White C (1987) Inhibition of galactosamine cytotoxicity in an in vivo/in vitro hepatocellular toxicity model. Toxicol Appl Pharmacol 89: 269

    Article  PubMed  CAS  Google Scholar 

  21. Oka JA, Weigel PH (1983) Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes: dissociation of internalized lig- and from receptor occurs in two kinetically and thermally distinguishable compartments. J Biol Chem 258: 10253

    PubMed  CAS  Google Scholar 

  22. Schanne FAX, Pfau RG, Farber JL (1980) Galactosamine-induced cell death in primary cultures of rat hepatocytes. Am J Pathol 100: 25

    PubMed  CAS  Google Scholar 

  23. Schwartz AL, Fridovich SE, Knowles BB, Lodish HF (1981) Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem 256: 8878

    PubMed  CAS  Google Scholar 

  24. Stockert RJ, Becker FF (1980) Diminished hepatic binding protein for desialylated glycoproteins during chemical hepatocarcinogenesis. Cancer Res 40: 3632

    PubMed  CAS  Google Scholar 

  25. Sweeney MJ, Parton JW, Hoffman DH (1974) Biosynthesis of uridine-5′-monophosphate in rat liver and Morris hepatomas. Adv Enzyme Regul 12: 385

    Article  PubMed  CAS  Google Scholar 

  26. Van der Sluijs P, Bootsma HP, Postema B, Moolenaar F, Meijer DKF (1986) Drug targeting to the liver with lactosylated albumins: does the glycoprotein target the drug or is the drug targeting the glycoprotein? Hepatology 6: 723

    Article  PubMed  Google Scholar 

  27. Warren L (1959) The thiobarbituric acid assay of sialic acids. J Biol Chem 234: 1971

    PubMed  CAS  Google Scholar 

  28. Weber G, Shiotani T, Kizaki H, Tzeng D, Williams JC, Gladstone N (1978) Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism. Adv Enzyme Regul 16: 3

    Article  CAS  Google Scholar 

  29. Wendel A, Tiegs G (1987) Leukotriene D4 mediates galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 36: 1867

    Article  PubMed  CAS  Google Scholar 

  30. Wu GY, Keegan-Rogers V, Franklin S, Midford S, Wu CH (1988) Targeted antagonism of galactosamine toxicity in normal rat hepatocytes in vitro. J Biol Chem 263: 4719

    PubMed  CAS  Google Scholar 

  31. Zar JH (1984) Biostatistical analysis. Prentice-Hall, Englewood Cliffs, New Jersey

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology-Liver Disease, University of Connecticut School of Medicine, 06032, Farmington, CT, USA

    Valerie Keegan-Rogers & George Y. Wu

Authors
  1. Valerie Keegan-Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Y. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keegan-Rogers, V., Wu, G.Y. Targeted protection of hepatocytes from galactosamine toxicity in vivo. Cancer Chemother Pharmacol 26, 93–96 (1990). https://doi.org/10.1007/BF02897251

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02897251

Keywords

Search

Navigation